• SENSEX 76,617.44
    592.93 (+0.78%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • IndusInd Bank
    708.45 1,576.00(%)
  • Kalyan Jewellers
    519.15 794.60(%)
  • Dr Lal Pathlabs
    2,508.00 3,645.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Vodafone Idea
    8.33 19.15(%)
  • Bharat Electron
    274.50 204.00(%)
  • Quadrant Future
    605.00 743.45(%)
  • Zomato Ltd
    212.60 304.50(%)
  • SRF
    2,986.25 3,074.95(%)
  • Bengal & Assam
    7,450.00 11,498.90(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • Mazagon Dock
    2,610.00 2,929.98(%)
  • Suzlon Energy
    57.74 86.04(%)
  • SpiceJet
    46.10 79.90(%)
  • Dixon Technolog.
    13,485.00 19,149.80(%)
  • Adani Green
    944.95 2,173.65(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Hind.Aeronautics
    4,252.00 5,675.00(%)
  • M & M
    2,660.50 3,276.30(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Divis Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 21188.0
  • ISIN : INE361B01024
5,549.70 -226 (-3.91%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    5,521.00

  • Today’s High

    5,818.50

  • Open

    5,749.50

  • Perv Close

    5,775.45

  • 52W Low

    3,450.00

  • 52W High

    6,285.45

Key Indicators

  • P/E(TTM)

    71.05

  • Mar.Cap (₹Cr.)

    147,327.10

  • Div & Yield %

    0.54

  • Book Value(₹)

    513.62

  • Debt-Equity Ratio

    -3.91

  • AGM Date

    01-Apr-2025

  • EPS

    78.09

  • P/E Ratio

    71.05

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    147,327.10

  • RONW (%)

    12.15

  • ROCE (%)

    16.41

Score Board

  • Equity (₹ in Cr.)

    53.09

  • BV (₹)

    513.60

  • Sales( ₹ in Cr.)

    7,665.00

  • NP (in Cr.)

    1,575.26

  • NP Var(%)

    -13.0

  • Div%

    1500.0

  • CPS (₹)

    73.50

  • EPS (₹)

    59.30

  • Traded Value (₹ in Lakhs)

    147,295.24

  • 52 Week High

    6,285.45

  • 52 Week Low

    3,450.00

  • Price BSE

    5549.0

  • Price NSE

    5,550.00

  • Market Capital( in Cr.)

    147,295.24

  • P/C Ratio

    75.50

  • P/E Ratio

    93.50

  • Price Vs.BV

    59.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 7,665.00 7,625.00 8,879.82 6,798.61 5,310.57 4,879.66
Excise Duty 7,603.00 7,504.00 8,708.10 6,541.90 5,198.31 4,727.84
Net Sales 7,665.00 7,625.00 8,879.82 6,798.61 5,310.57 4,879.66
Other Income 337.00 349.00 111.26 62.53 189.86 156.58
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 8,002.00 7,974.00 8,991.08 6,861.14 5,500.43 5,036.24
EXPENDITURE :
Raw Materials 7,603.00 7,504.00 8,708.10 6,541.90 5,198.31 4,727.84
Power & Fuel Cost 7,603.00 7,504.00 8,708.10 6,541.90 5,198.31 4,727.84
Employee Cost 1,067.00 953.00 926.55 808.68 608.36 530.72
Other Manufacturing Expenses 138.00 56.00 42.03 38.81 68.97 63.98
Selling & Administrative Expenses 367.00 403.00 342.68 302.24 235.72 171.96
Miscellaneous Expenses 138.00 56.00 42.03 38.81 68.97 63.98
Less : Pre-operative Expenses Capitalised :
Total Expenditure 5,870.00 5,620.00 5,314.56 4,233.27 3,687.14 3,203.01
Operating Profit 836.00 836.00 702.30 562.70 493.52 426.21
Interest 3.00 1.00 0.65 0.69 6.06 3.50
Gross Profit 2,132.00 2,354.00 3,676.52 2,627.87 1,813.29 1,833.23
Depreciation 376.00 342.00 310.55 254.65 185.95 168.81
Profit Before Tax 2,132.00 2,354.00 3,676.52 2,627.87 1,813.29 1,833.23
Tax 514.00 439.00 634.39 615.80 421.49 471.90
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 45.00 108.00 90.78 64.10 52.79 28.13
Reported Net Profit 1,576.00 1,808.00 2,948.54 1,954.72 1,372.71 1,332.65
Extraordinary Items 2,132.00 2,354.00 3,676.52 2,627.87 1,813.29 1,833.23
Adjusted Net Profit 1,576.00 1,808.00 2,948.54 1,954.72 1,372.71 1,332.65
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 796.00 796.00 796.41 530.94 424.75 424.75
P & L Balance carried down 1,576.00 1,808.00 2,948.54 1,954.72 1,372.71 1,332.65
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 1,500.00 1,500.00 1,500.00 1,000.00 800.00 800.00
Dividend Per Share(Rs) 30.00 30.00 30.00 20.00 16.00 16.00
Earnings Per Share-Unit Curr 59.37 68.11 111.07 73.63 51.71 50.20
Book Value 796.00 796.00 796.41 530.94 424.75 424.75
Book Value(Adj)-Unit Curr 796.00 796.00 796.41 530.94 424.75 424.75

Shareholding Pattern

  • Promoter Group

    51.89%

  • Public Share Holding

    48.11%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,000,000 3.01 8,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 129,755,090 48.88 129,755,090 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 137,755,090 51.89 137,755,090 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1,666 0.00 1,666 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 198,767 0.07 198,767 6
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 47,746,859 17.99 47,746,859 720
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 20,339,261 7.66 20,339,261 29
Mutual Funds / UTI 31,563,780 11.89 31,563,780 35
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,418,077 0.91 2,418,077 33
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 102,268,410 38.52 102,268,410 826
2] Non Institution
Bodies Corporate 3,368,375 1.27 3,368,375 1,924
Clearing Members 27,265 0.01 27,265 16
Directors of their Relatives 841,811 0.32 841,811 12
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,387,154 0.52 1,387,154 10,318
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 319,523 0.12 319,523 3,611
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,283,500 0.48 1,283,500 7
Individuals holding nominal share capital up to Rs. 1 lakh 18,156,905 6.84 18,082,494 263,848
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 32,959 0.01 32,959 30
Others 27,588 0.01 27,588 3
Sub Total 25,445,080 9.59 25,370,669 279,769
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 265,468,580 100.00 265,394,169 280,601

Company Background

Divis Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Divis Laboratories Ltd
  • BSE Code : 21188.0
  • ISIN : INE361B01024

  • Incorporation Year

    1990

  • Registered Office

    1-72-23(P)/DIVIS/303 Divi Towe
    Cyber Hills Gachibowli, Hyderabad,
    Telangana-500032

  • Telephone

    91-40-23786300/23786352/400

  • FAX

    91-40-23786460

  • Chairman

    Ramesh B V Nimmagadda

  • Managing Director

    Murali K Divi

  • Company Secretary

    Satish Choudhury

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Divis Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Divi's Lab. 5,548.50 8,002.00 7,665.00 71.05 16.27
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92